1. Home
  2. EDAP vs RPTX Comparison

EDAP vs RPTX Comparison

Compare EDAP & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • RPTX
  • Stock Information
  • Founded
  • EDAP 1979
  • RPTX 2016
  • Country
  • EDAP France
  • RPTX Canada
  • Employees
  • EDAP N/A
  • RPTX N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RPTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDAP Health Care
  • RPTX Health Care
  • Exchange
  • EDAP Nasdaq
  • RPTX Nasdaq
  • Market Cap
  • EDAP 53.8M
  • RPTX 63.9M
  • IPO Year
  • EDAP 1997
  • RPTX 2020
  • Fundamental
  • Price
  • EDAP $1.54
  • RPTX $1.51
  • Analyst Decision
  • EDAP Buy
  • RPTX Strong Buy
  • Analyst Count
  • EDAP 3
  • RPTX 3
  • Target Price
  • EDAP $8.50
  • RPTX $4.50
  • AVG Volume (30 Days)
  • EDAP 44.7K
  • RPTX 686.2K
  • Earning Date
  • EDAP 08-27-2025
  • RPTX 08-05-2025
  • Dividend Yield
  • EDAP N/A
  • RPTX N/A
  • EPS Growth
  • EDAP N/A
  • RPTX N/A
  • EPS
  • EDAP N/A
  • RPTX N/A
  • Revenue
  • EDAP $67,840,467.00
  • RPTX $1,073,000.00
  • Revenue This Year
  • EDAP N/A
  • RPTX N/A
  • Revenue Next Year
  • EDAP N/A
  • RPTX N/A
  • P/E Ratio
  • EDAP N/A
  • RPTX N/A
  • Revenue Growth
  • EDAP 3.69
  • RPTX N/A
  • 52 Week Low
  • EDAP $1.26
  • RPTX $0.89
  • 52 Week High
  • EDAP $5.17
  • RPTX $4.29
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 41.95
  • RPTX 55.89
  • Support Level
  • EDAP $1.51
  • RPTX $1.37
  • Resistance Level
  • EDAP $1.59
  • RPTX $1.68
  • Average True Range (ATR)
  • EDAP 0.09
  • RPTX 0.08
  • MACD
  • EDAP 0.00
  • RPTX 0.00
  • Stochastic Oscillator
  • EDAP 32.14
  • RPTX 50.00

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Share on Social Networks: